SCHEMBL8932070

SCHEMBL8932070

CCCC(I)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
POLB P06746 2/20 0.40
CPB2 Q96IY4 2/20 0.39
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
CHRM1 P11229 1/20 0.37
AKR1A1 P14550 1/20 0.37
CHRM3 P20309 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37
HRH1 P35367 1/20 0.37
DRD3 P35462 1/20 0.37
SLC6A3 Q01959 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2868252 0.90 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10POLBCPB2
SCHEMBL6817900 0.86 CA2 (0.44) ALDH1A1LMNAHSD17B10POLBCPB2
SCHEMBL2865545 0.86 CPB2 (0.47) ALDH1A1LMNAHSD17B10POLBCPB2
SCHEMBL21811976 0.86 HDAC1 (0.37) ALDH1A1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL6761975 0.86 CPB2 (0.43) ALDH1A1LMNAHSD17B10POLBCPB2
SCHEMBL27962385 0.85 ZDHHC7 (0.44) CPB2
SCHEMBL21811422 0.84 HDAC1 (0.38) ALDH1A1LMNACHRM1AKR1A1CHRM3
SCHEMBL7067176 0.84 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10POLBCPB2
SCHEMBL29190379 0.83 TDP1 (0.39) ALDH1A1LMNAHSD17B10SOAT1CHRM1
SCHEMBL6821576 0.83 ZDHHC7 (0.47) CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103910741-A Bisbenzylisoquinoline betaine as well as preparation method thereof and application thereof in preparation of anti-tumor medicament UNIV SHANDONG NORMAL 2014-07-09 CN claimed
US-12534563-B2 Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film ARTIENCE CO., LTD. (JP) 2026-01-27 US disclosed
EP-4406979-B1 COMPOUND AND PRODUCTION METHOD FOR COMPOUND DENKA COMPANY LTD (JP) 2025-11-12 EP disclosed
US-20240400740-A1 COMPOUND AND METHOD OF PRODUCING THE COMPOUND DENKA COMPANY LIMITED (JP) 2024-12-05 US disclosed
EP-4406979-A1 COMPOUND AND PRODUCTION METHOD FOR COMPOUND Denka Company Limited (JP) 2024-07-31 EP disclosed
EP-3106472-B1 LIVING RADICAL POLYMERIZATION CATALYST, AND POLYMER PRODUCTION METHOD USING SAME UNIV KYOTO (JP) 2024-05-29 EP disclosed
CN-118076649-A Compound and method for producing the same 电化株式会社 2024-05-24 CN disclosed
US-11958802-B2 Migration-resistant photopolymerization sensitizer KAWASAKI KASEI CHEMICALS LTD. (JP) 2024-04-16 US disclosed
CN-117412997-A Water-absorbent resin composition, and absorbent article using same 三大雅株式会社 2024-01-16 CN disclosed
CN-113166036-B Photopolymerizing sensitizers with migration resistance 川崎化成工业株式会社 2023-10-10 CN disclosed
CN-108137728-A Water-absorbent besin particles and its manufacturing method 三大雅株式会社 2018-06-08 CN disclosed
US-9926386-B2 Living radical polymerization catalyst, and polymer production method using same KYOTO UNIVERSITY (JP) 2018-03-27 US disclosed
US-9926386-B2 Living radical polymerization catalyst, and polymer production method using same KYOTO UNIVERSITY (JP) 2018-03-27 US disclosed
EP-3106472-A1 LIVING RADICAL POLYMERIZATION CATALYST, AND POLYMER PRODUCTION METHOD USING SAME Kyoto University (JP) 2016-12-21 EP disclosed
US-20160347872-A1 LIVING RADICAL POLYMERIZATION CATALYST, AND POLYMER PRODUCTION METHOD USING SAME KYOTO UNIVERSITY (JP) 2016-12-01 US disclosed
US-20160347872-A1 LIVING RADICAL POLYMERIZATION CATALYST, AND POLYMER PRODUCTION METHOD USING SAME KYOTO UNIVERSITY (JP) 2016-12-01 US disclosed
US-20160347872-A1 LIVING RADICAL POLYMERIZATION CATALYST, AND POLYMER PRODUCTION METHOD USING SAME KYOTO UNIVERSITY (JP) 2016-12-01 US disclosed
CN-103910741-A Bisbenzylisoquinoline betaine as well as preparation method thereof and application thereof in preparation of anti-tumor medicament UNIV SHANDONG NORMAL 2014-07-09 CN disclosed
CN-103910738-A Bisbenzylisoquinoline quaternary ammonium salt as well as preparation method and application thereof in preparing antitumor drug UNIV SHANDONG NORMAL 2014-07-09 CN disclosed
US-5681940-A CONTAIN TETRAHYDROTHIOPHENE OR PYROLIDINE RINGS ICN PHARMACEUTICALS (US) 1997-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534563-B2 Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film EPB41, ITGB4, ITGB5 ALDH1A1 2727/4885LMNA 1582/4885HSD17B10 3658/4885
US-11958802-B2 Migration-resistant photopolymerization sensitizer F12, F10, PCNA ALDH1A1 838/4885LMNA 54/4885HSD17B10 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.